Latest News for: rho kinase

Edit

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Pharmiweb 28 Mar 2025
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE ... “Dr ... AURN001 is a combination cell therapy product candidate comprised of allogeneic human corneal endothelial cells ( neltependocel ) and a rho kinase inhibitor (Y-27632) ... Lacoste ... and Canada ... .
  • 1
×